Skip to main content
Log in

Cognitive Impairment in Patients with Type 1 (Insulin-Dependent) Diabetes Mellitus

Incidence, Mechanisms and Therapeutic Implications

  • Clinical Concepts
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Patients with type 1 (insulin-dependent) diabetes mellitus can experience both very low and very high blood glucose levels that may affect the CNS. Over time, high glucose levels (hyperglycaemia) may result in ketoacidosis, seizures, coma and death. Although a wide variation in response exists, acute hypoglycaemia (low blood sugar level) generally results in a decrease in the supply of glucose to the brain. Progressively lower glucose levels can result in confusion, inability to concentrate or cogitate, seizures, coma or death.

Much progress has been made in the understanding of systemic and brain glucose metabolism, and the metabolic changes that are associated with type 1 diabetes mellitus. Research during the last 2 decades has clarified specific cognitive function and cognitive deficits during glucose fluctuations, particularly hypoglycaemia. In addition, recent research efforts have attempted to differentiate between the acute and chronic influences of glycaemic level on brain physiology and function, and to determine if glucose fluctuations lead to permanent intellectual impairment. Additional studies have examined the mechanisms underlying the potentiating effect of alcohol (ethanol) on insulin-induced hypoglycaemia. Finally, clinical interventions have been developed that are directed at the prevention and early treatment of hypoglycaemia through careful management of insulin dose and timing and through extensive patient and family education.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Krolewski AS, Warram JH, Rand LI, et al. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 1987; 317: 1390–8

    PubMed  CAS  Google Scholar 

  2. Jones DB, Gill GV. Insulin-dependent diabetes mellitus. In: Pickup JC, Williams G, editors. Textbook of diabetes. 2nd ed. Oxford: Blackwell Scientific Publications, 1997: 12.1–12.13

    Google Scholar 

  3. Reichard P, Britz A, Rosenqvist U. Intensified conventional insulin treatment and neuropsychological impairment. BMJ 1991; 303: 1439–42

    PubMed  CAS  Google Scholar 

  4. Diabetes Control and Complications Trial Research Group. Ef- fects of intensive diabetes therapy on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86

    Google Scholar 

  5. Cryer PE. Glucose counterregulation: the physiological mechanisms that prevent or correct hypoglycemia. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 34–55

    Google Scholar 

  6. Cryer PE, Frier BM. Hypoglycaemia. In: Alberti KGMM, Zimmet P, Defronzo RA, et al., editors. International textbook of diabetes mellitus. Chichester: John Wiley & Sons, 1997: 1193–214

    Google Scholar 

  7. Polonsky K, Bergenstal R, Pons G, et al. Relation of counter- regulatory response to hypoglycemia in type 1 diabetes. N Engl J Med 1982; 307: 1106–2

    PubMed  CAS  Google Scholar 

  8. Gerich JE, Bolli GB. Counterregulatory failure. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 253–67

    Google Scholar 

  9. Simonson DC, Tamborlane WV, DeFronzo RA, et al. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with Type I diabetes. Ann Intern Med 1985; 103: 184–90

    PubMed  CAS  Google Scholar 

  10. Robinson AM, Parkin HM, Macdonald IA, et al. Physiological response to postural change during mild hypoglycemia in patients with IDDM. Diabetologia 1994; 37: 1241–50

    PubMed  CAS  Google Scholar 

  11. Debrah K, Sherwin RS, Murphy J, et al. Effect of caffeine on the recognition of and responses to hypoglycemia in insulin-dependent diabetes mellitus. Lancet 1996; 347: 19–24

    PubMed  CAS  Google Scholar 

  12. Kerr D, Sherwin RS, Pavalkis F, et al. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Ann Intern Med 1993; 119: 799–804

    PubMed  CAS  Google Scholar 

  13. Siesjo BK. Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev 1988; 4: 113–44

    PubMed  CAS  Google Scholar 

  14. Auer RN, Siesjö B. Hypoglycaemia: brain neurochemistry and neuropathy. Baillieres Clin Endocrin Metab 1993; 7: 611–24

    CAS  Google Scholar 

  15. McCall AL. Effects of glucose deprivation on glucose metabolism in the central nervous system. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 56–71

    Google Scholar 

  16. Simpson IA, Vannucci SJ, Maher F. Glucose transporters in mammalian brain. Biochem Soc Trans 1994; 22: 671–5

    PubMed  CAS  Google Scholar 

  17. Burchell A, Hume R. The glucose-6-phosphate system in human development. Histol Histopathol 1995; 10: 979–93

    PubMed  CAS  Google Scholar 

  18. Amiel SA. Glucose counter-regulation in health and disease: current concepts in hypoglycemia recognition and response. Q J Med 1991; 80: 707–27

    PubMed  CAS  Google Scholar 

  19. Cryer PE. Regulation of glucose metabolism in man. J Intern Med 1991; 229: 31–9

    Google Scholar 

  20. Amiel SA, Gale E. Physiological responses to hypoglycemia: counterregulation and cognitive function. Diabetes Care 1993; 16: 48–55

    PubMed  Google Scholar 

  21. White MF, Kahn CR. Molecular aspects of insulin action. In: Kahn CR, Weir GC, editors. Joslin’s diabetes mellitus. Philadelphia: Lea & Febiger, 1994: 139–62

    Google Scholar 

  22. Kumagai AK, Kang YS, Boado RJ, et al. Upregulation of blood-brain-barrier Glutl glucose transporter protein and mRNA experimental chronic hypoglycemia. Diabetes 1995; 44: 1399–404

    PubMed  CAS  Google Scholar 

  23. McCall AL, Millington WR, Wurtman RJ. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci USA 1982; 79: 5406–10

    PubMed  CAS  Google Scholar 

  24. Lutz AJ, Pardridge WM. Insulin therapy normalizes Glutl glucose transporter mRNA but not immunoreactive transporter protein in streptozocin-diabetic rats. Metabolism 1993; 42: 939–44

    PubMed  CAS  Google Scholar 

  25. Cornford EM, Hyman S, Cornford ME, et al. Down-regulation of blood brain glucose transport in the hyperglycemic non-obese diabetic mouse. Neurochem Res 1995; 20: 869–73

    PubMed  CAS  Google Scholar 

  26. McCall AL, Fixman LB, Fleming N, et al. Chronic hypoglycemia increases brain glucose transport. Am J Physiol 1986; 251 (Endocrinol Metab 14): E442–7

    PubMed  CAS  Google Scholar 

  27. Pelligrino DA, Segil LJ, Albrecht RF. Brain glucose utilization and transport and cortical function in chronic vs acute hypoglycemia. Am J Physiol 1990; 259: E729–35

    PubMed  CAS  Google Scholar 

  28. Pardridge WM, Triguero D, Farrell CR. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 1990; 39: 1040–4

    PubMed  CAS  Google Scholar 

  29. McCall AL. The impact of diabetes on the CNS. Diabetes 1992; 41: 557–70

    PubMed  CAS  Google Scholar 

  30. Boyle PJ, Nagy RJ, O’Connor AM, et al. Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 1994; 91: 9352–6

    PubMed  CAS  Google Scholar 

  31. Boyle PJ, Kempers SF, O’Connor AM, et al. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl JMed 1995; 333: 1726–31

    CAS  Google Scholar 

  32. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995

    Google Scholar 

  33. Heller SR, Macdonald IA. The measurement of cognitive function during acute hypoglycemia: experimental limitations and their effect on the study of glucose awareness. Diabetic Med 1996; 13: 607–15

    PubMed  CAS  Google Scholar 

  34. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–23

    PubMed  CAS  Google Scholar 

  35. Boyle PJ. Glucose clamp investigations: the ups and downs. Diabetes Care 1994 17: 239–41

    PubMed  CAS  Google Scholar 

  36. Stevens AB, McKane WR, Bell PM, et al. Psychomotor performance and counterregulatory responses during mild hypoglycemia in healthy volunteers. Diabetes Care 1989; 12: 12–7

    PubMed  CAS  Google Scholar 

  37. Kerr D, Macdonald IA, Tattersall RB. Adaptation to mild hypoglycaemia in normal subjects despite sustained increases in counter-regulatory hormones. Diabetologia 1989; 32: 249–54

    PubMed  CAS  Google Scholar 

  38. Ipp E, Forster B. Sparing of cognitive function in mild hypoglycemia: dissociation from the neuroendocrine process. J Clin Endocrin Metab 1987; 65: 806–10

    CAS  Google Scholar 

  39. Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 1991; 260 (Endocrinol Metab 23): E67–74

    PubMed  CAS  Google Scholar 

  40. Hvidberg A, Fanelli CG, Hershey T, et al. Impact of antecedent hypoglycemia on hypoglycemic cognitive function in nondiabetic humans. Diabetes 1996; 45: 1030–6

    PubMed  CAS  Google Scholar 

  41. Fourest-Fontecave S, Asamson U, Lins PE, et al. Mental alertness in response to hypoglycemia in normal man: the effect of 12 hours and 72 hours of fasting. Diabete Metab 1987; 13: 405–10

    PubMed  CAS  Google Scholar 

  42. Kerr D, Stanley JC, Barron M, et al. Symmetry of cerebral blood flow and cognitive responses to hypoglycemia in humans. Diabetologia 1993; 36: 73–8

    PubMed  CAS  Google Scholar 

  43. Holmes CS, Hayford JT, Gonzalez JL, et al. A survey of cognitive functioning at different glucose levels in diabetic persons. Diabetes Care 1983; 112: 193–7

    Google Scholar 

  44. Holmes CS. Metabolic control and auditory information processing at altered blood glucose levels in insulin-dependent diabetes. Brain Cogn 1987; 6: 161–74

    PubMed  CAS  Google Scholar 

  45. Holmes CS, Koepke KM, Thompson RG. Simple versus complex performance impairments at three blood glucose levels. Psychoneuroendocrinology 1986; 11: 353–7

    PubMed  CAS  Google Scholar 

  46. Holmes CS, Koepke KM, Thompson RG, et al. Verbal fluency and naming performance in type 1 diabetes at different blood glucose concentrations. Diabetes Care 1984; 7: 454–9

    PubMed  CAS  Google Scholar 

  47. Hoffman RG, Speelman DJ, Hinnen DA, et al. Changes in cortical functioning with acute hypoglycemia and hyperglycemia in type 1 diabetes. Diabetes Care 1989; 112: 193–7

    Google Scholar 

  48. Gonder-Frederick LA, Cox DJ, Driesen NR, et al. Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes 1994; 43: 1407–12

    PubMed  CAS  Google Scholar 

  49. Cranston I, Iomas J, Maran A, et al. Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344: 283–7

    PubMed  CAS  Google Scholar 

  50. Draelos MT, Jacobson A, Weinger K, et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med 1995; 98: 135–44

    PubMed  CAS  Google Scholar 

  51. Lingenfelser T, Overkamp D, Renn W, et al. Cognitive and psychomotor function during severe insulin-induced hypoglycemia in insulin-dependent diabetic patients. Neuro-psychobiology 1992; 25: 161–5

    CAS  Google Scholar 

  52. Pramming S, Thorsteinsson B, Theilgaard A, et al. Cognitive function during hypoglycemia in type 1 (insulin-dependent) diabetes mellitus. BMJ 1986; 292: 647–50

    PubMed  CAS  Google Scholar 

  53. Herold KC, Polonsky KS, Cohen RM, et al. Variable deterioration in cortical function during insulin-induced hypoglycemia. Diabetes 1985; 34: 677–85

    PubMed  CAS  Google Scholar 

  54. Blackman JD, Towle VL, Sturis J, et al. Hypoglycémie thresh- old for cognitive dysfunction in IDDM. Diabetes 1992; 41: 392–9

    PubMed  CAS  Google Scholar 

  55. Heller SR, Macdonald IA, Herbert M, et al. Influence of sympathetic nervous system on hypoglycemic warning symptoms. Lancet 1987; 2: 359–63

    PubMed  CAS  Google Scholar 

  56. Widom B, Simonson DC. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1990; 112: 904–12

    PubMed  CAS  Google Scholar 

  57. Maran A, Lomas J, Macdonald IA, et al. Lack of preservation of higher brain function during hypoglycemia in patients with intensively-treated IDDM. Diabetologia 1995; 38: 1412–8

    PubMed  CAS  Google Scholar 

  58. Wirsén A, Tallroth G, Lindgren M, et al. Neuropsychological performance differs between type 1 diabetic and normal men during insulin-induced hypoglycemia. Diabetic Med 1992; 9: 1156–65

    Google Scholar 

  59. Harrad RA, Cockram CS, Plumb AP, et al. The effect of hypoglycaemia on visual function: a clinical and electrophysiological study. Clin Sci 1985; 69: 673–9

    PubMed  CAS  Google Scholar 

  60. Pietravalle P, Cristina G, Morano S, et al. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis: comparison with short-latency evoked potentials and psychomotor tests. Diabetes 1991; 40: 952–8

    PubMed  Google Scholar 

  61. Tamburrano G, Lala A, Locuratolo N, et al. Electroencephalography and visually evoked potentials during moderate hypoglycemia. J Clin Endocrin Metab 1988; 66: 1301–6

    CAS  Google Scholar 

  62. Jones TW, McCarthy G, Tamborlane WV, et al. Mild hypoglycemia and impairment of brainstem and cortical evoked potentials in healthy subjects. Diabetes 1990; 39: 1550–5

    PubMed  CAS  Google Scholar 

  63. Gallai V, Mazzotta G, Firenze C, et al. A study of the P300 component during minor hypoglycemia. Acta Neurol 1988; 10: 178–86

    CAS  Google Scholar 

  64. De Feo P, Gallai V, Mazzotta G, et al. Modest decrements in plasma glucose concentrations cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 1988; 82: 436–44

    PubMed  Google Scholar 

  65. Ziegler D, Hübinger A, Mühlen H, et al. Effects of previous control on the onset and magnitude of cognitive dysfunction during hypoglycemia in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 828–34

    PubMed  CAS  Google Scholar 

  66. Blackman JD, Towle VL, Sturis J, et al. Hypoglycémie threshold for cognitive dysfunction in humans. Diabetes 1990; 39: 828–35

    PubMed  CAS  Google Scholar 

  67. Tallroth G, Lindgren M, Stenberg G, et al. Neurophysiological changes during insulin-induced hypoglycemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 1990; 33: 319–23

    PubMed  CAS  Google Scholar 

  68. Ziegler D, Hübinger A, Gries, et al. Changes in brainstem auditory evoked potentials during insulin-induced hypoglycemia in type 1 diabetic patients. Diabetic Med 1991; 8: 805–11

    PubMed  CAS  Google Scholar 

  69. Lingenfelser T, Buettner UW, Plonz C, et al. Hormonal counterregulation, symptom awareness, and neurophysiological function in type 1 diabetes during insulin-induced hypoglyce- mia. Diabetic Med 1992; 9: 528–35

    PubMed  CAS  Google Scholar 

  70. Lingenfelser T, Buettner LW, Sommerwerck U, et al. Neurophysiological impairments in IDDM patients during euglyce- mia and hypoglycemia. Diabetes Care 1993; 11: 1438–45

    Google Scholar 

  71. Lingenfelser T, Renn W, Sommerwerck U, et al. Comprised hormonal counterregulation, symptom awareness, and neuro- physiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes 1993; 42: 610–8

    PubMed  CAS  Google Scholar 

  72. Deary IJ. Effects of hypoglycemia on cognitive function. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 80–92

    Google Scholar 

  73. Ruff RR, Crouch JA. Neuropsychological test instruments in clinical trials. In: Mohr E, Brouwers P, editors. Handbook of clinical trials: the neurobehavioral approach. Amsterdam: Swets & Zeitlinger, 1991: 89–119

    Google Scholar 

  74. Posner MI. Structures and functions of selective attention. In: Boll T, Bryant BK, editors. Clinical neuropsychology and brain function. Washington, DC: American Psychological Association, 1988: 173–202

    Google Scholar 

  75. van Zomeran AH, Brouwer WH. Clinical neuropsychology of attention. New York: Oxford University Press, 1994

    Google Scholar 

  76. Goldstein G. Comprehensive neuropsychologic assessment batteries. In: Goldstein G, Hersen M, editors. Handbook of psychological assessment. New York: Pergamon Press, 1992: 197–227

    Google Scholar 

  77. Weinger K. Limits on learning: the effect of hypoglycemia and hyperglycemia on cognitive function in adults with IDDM. [dissertation]. Cambridge: Harvard University, 1996

    Google Scholar 

  78. Ryan CM, Williams TM, Orchard TJ, et al. Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 1992; 41: 107–13

    PubMed  CAS  Google Scholar 

  79. Cox DJ, Gonder-Frederick LA, Clarke W. Driving decrements in type 1 diabetes during moderate hypoglycemia. Diabetes 1993; 42: 239–43

    PubMed  CAS  Google Scholar 

  80. Cox DJ, Gonder-Frederick LA, Schroeder DB, et al. Disruptive effects of acute hypoglycemia on speed of cognitive and motor performance. Diabetes Care 1993; 16: 1391–3

    PubMed  CAS  Google Scholar 

  81. Amiel SA, Pottinger RC, Archibald HR, et al. Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care 1991; 14: 109–18

    PubMed  CAS  Google Scholar 

  82. Duncan-Johnson CC, Donchin E. The P300 component of the event-related brain potential as an index of information processing. Biol Psychology 1982; 14: 1–52

    CAS  Google Scholar 

  83. Smid HGOD, Trümper BG, Pottag G, et al. Differentiation of hypoglycaemia induced cognitive impairments: an electrophysiological approach. Brain 1997; 120: 1041–56

    PubMed  Google Scholar 

  84. AckM, Miller I, Weil WB. Intelligence of children with diabetes mellitus. Pediatrics 1961; 25: 462–7

    Google Scholar 

  85. Ryan CM, Vega A, Drash A. Cognitive defects in adolescents who developed diabetes early in life. Pediatrics 1985; 25: 921–7

    Google Scholar 

  86. Rovet JF, Ehrlich RM, Hoppe M. Intellectual deficits associated with early onset of insulin dependent diabetes mellitus in children. Diabetes Care 1987; 10: 510–5

    PubMed  CAS  Google Scholar 

  87. Rovet JF, Ehrlich RM, Hoppe M. Specific intellectual deficits in children with early onset of diabetes mellitus. Child Dev 1988; 59: 226–34

    PubMed  CAS  Google Scholar 

  88. Golden MP, Ingersoll GM, Btack CJ, et al. Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 1989; 12: 89–93

    PubMed  CAS  Google Scholar 

  89. Ryan CM, Atchison J. Puczynski S, et al. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. J Pediatrics 1990; 117: 32–8

    CAS  Google Scholar 

  90. McCall AL, Figlewicz DP. How does diabetes mellitus produce brain dysfunction? Diabetes Spect 1997; 10: 25–32

    Google Scholar 

  91. Cryer PE. Hypoglycemia: the limiting factor in management of IDDM. Diabetes 1994; 229: 31–9

    Google Scholar 

  92. Rovet J, Alvarez M. Attentional functioning in children and adolescent with IDDM. Diabetes Care 1997; 20: 803–10

    PubMed  CAS  Google Scholar 

  93. Bjørgaas M, Gimse, Vik T, et al. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycemia. Acta Paediatr 1997; 86: 148–53

    PubMed  Google Scholar 

  94. Ryan C, Longstreet C, Morrow L. The effects of diabetes mellitus on the school attendance and school achievement of adolescents. Child Care Health Dev 1985; 11: 229–40

    PubMed  CAS  Google Scholar 

  95. Puczynski S. Neurocognitive effects of diabetes in children and adolescents: disease-related and psychosocial effects on cog- nitive performance and classroom performance. Diabetes Spect 1997; 10: 51–7

    Google Scholar 

  96. Holmes CS, Dunlap WP, Chen RS, et al. Gender differences in the learning status of diabetic children. J Counseling Clin Psychol 1992; 60; 698–704

    CAS  Google Scholar 

  97. Donald MW, Williams Erdahl DL, et al. Functional correlates of reduced central conduction velocity in diabetic subjects. Diabetes 1984; 33: 627–33

    PubMed  CAS  Google Scholar 

  98. Pozzessere G, Rizzo PA, Valle E, et al. Early detection of neurological involvement in IDDM and NIDDM. Diabetes Care 1988; 11: 473–80

    PubMed  CAS  Google Scholar 

  99. Pozzessere G, Valle E, De Criginis S, et al. Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Diabetes 1991; 40: 952–8

    PubMed  CAS  Google Scholar 

  100. Dejgaard A, Gade A, Larsson H, et al. Evidence for diabetic encephalopathy. Diabetic Med 1991; 8: 162–7

    PubMed  CAS  Google Scholar 

  101. Perrors P, Deary II, Seller RJ, et al. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of severe hypoglycemia. Diabetes Care 1997; 20: 1013–8

    Google Scholar 

  102. Meuter F, Thomas W, Grunneklee D, et al. Psychometric evaluation of performance in diabetes mellitus. Horm Metabolic Res 1980; Suppl. 9: 9-17

    Google Scholar 

  103. Franceschi M, Ceccetto R, Minicucci F, et al. Cognitive processes in insulin-dependent diabetes. Diabetes Care 1984; 7: 228–31

    PubMed  CAS  Google Scholar 

  104. Skenary I, Bigler E. Neuropsychological findings in diabetes mellitus. I Clin Psychol 1984; 40: 246–58

    Google Scholar 

  105. Ryan CM. Neurobehavioral complications of Type I diabetes: examination of possible risk factors. Diabetes Care 1988; 11: 86–93

    PubMed  CAS  Google Scholar 

  106. Ryan CM, Williams TM, Finegold DN, et al. Cognitive dys- function in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effect of recurrent hypoglycemia and other chronic complications. Diabetologia 1993; 36: 329–34

    PubMed  CAS  Google Scholar 

  107. Ryan CM, Williams, TM. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. I Clin Expl Neuropsychol 1993; 15: 686–700

    Google Scholar 

  108. Prescott JH, Richardson JTE, Gillespie CR. Cognitive function in diabetes mellitus: the effects of duration of illness and glycaemic control. Br J Clin Psychol 1990; 26: 167–75

    Google Scholar 

  109. Frier BM, Hilsted I. Does hypoglycemia aggravate the complications of diabetes? Lancet 1985; II: 1175–7

    Google Scholar 

  110. Cirillo D, Gonfiantini E, De Grandis D, et al. Visual evoked potentials in diabetic children and adolescents. Diabetes Care 1984; 7: 273–5

    PubMed  CAS  Google Scholar 

  111. Bax G, Lelli S, Grandis U, et al. Early involvement of central nervous system in type I diabetic patients. Diabetes Care 1995; 18: 559–62

    PubMed  CAS  Google Scholar 

  112. Deary II. Debate: does frequent severe hypoglycemia cause significant cognitive decrements? Hypoglycemia-induced cognitive decrements in adults with type 1: a case to answer? Diabetes Spect 1997; 10: 42–7

    Google Scholar 

  113. Reichard P. Hypoglycemia-induced cognitive decrements in adults with Type 1: a case to answer? Diabetes Spect 1997; 10: 48–50

    Google Scholar 

  114. Deary II, Frier BM. Intensified conventional insulin treatment and neuropsychological impairment [letter]. BMI 1992; 304: 447

    CAS  Google Scholar 

  115. Reichard P. Intensified conventional insulin treatment and neuropsychological impairment [letter]. BMI 1992; 304: 447

    Google Scholar 

  116. Bale RN. Brain damage in diabetes mellitus. Br I Psychiatry 1973; 122: 337–41

    CAS  Google Scholar 

  117. Wredling R, Levander S, Adamson U, et al. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycemia in man. Diabetologia 1990; 33: 152–7

    PubMed  CAS  Google Scholar 

  118. Langan KI, Deary IA, Hepburn DA, et al. Cumulative cognitive impairment following recurrent severe hypoglycemia in adult patients with insulin-dependent diabetes mellitus. Diabetologia 1991; 34: 337–44

    PubMed  CAS  Google Scholar 

  119. Deary II, Langan SI, Graham KS, et al. Recurrent severe hypoglycemia, intelligence, and speed of information processing. Intelligence 1992; 16: 337–59

    Google Scholar 

  120. Deary II, Crawford IR, Hepburn DA, et al. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 1993; 42: 341–4

    PubMed  CAS  Google Scholar 

  121. Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996; 124: 379–88

    Google Scholar 

  122. Holmes CS. Neuropsychological sequelae of acute and chronic blood glucose disruption in adults with insulin-dependent diabetes. In: Holmes CS, editor. Neurospsychological and behavioral aspects of diabetes. New York: Springer-Verlag, 1989: 122–54

    Google Scholar 

  123. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991; 40: 223–6

    PubMed  CAS  Google Scholar 

  124. George E, Harris N, Bedford C, et al. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycemia in normal subjects. Diabetologia 1995; 38: 1183–90

    PubMed  CAS  Google Scholar 

  125. Puczynski MS, Puczynski SS, Reich I, et al. Mental efficiency and hypoglycemia. I Dev Behav Pediatr 1990; 11: 170–4

    CAS  Google Scholar 

  126. Bendtson I, Gade I, Theilgaard A, et al. Cognitive function in Type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia. Diabetologia 1992; 35: 898–903

    PubMed  CAS  Google Scholar 

  127. Bendtson I. Nocturnal hypoglycaemia in patients with insulin-dependent diabetes mellitus. Dan Med Bull 1995; 42: 269–84

    PubMed  CAS  Google Scholar 

  128. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993; 42: 1683–9

    PubMed  CAS  Google Scholar 

  129. Bolli G, DeFeo P, Compagnucci P, et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin and impaired glucagon secretion. Diabetes 1983; 32: 134–41

    PubMed  CAS  Google Scholar 

  130. Amiel SA, Tamborlane WV, Saccà L, et al. Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects. Diabetes Metab Rev 1988; 4: 71–89

    PubMed  CAS  Google Scholar 

  131. Krolewski AS, Warram JH. Epidemiology of late complications of diabetes. In: Kahn CR, Weir GC, editors. Joslin’s diabetes mellitus. Philadelphia: Lea & Febiger, 1994: 605–19

    Google Scholar 

  132. Widom B, Kinsley B, Simonson DC. Women and men dffer in counterregulatory hormone responses in patients with insulin-dependent diabetes mellitus [abstract]. Diabetes 1991; 40Suppl. 1: 543A

    Google Scholar 

  133. Amiel SA, Maran A, Powrie JK, et al. Gender influences counter-regulatory hormone responses to hypoglycemia. Diabetologia 1993; 36: 460–4

    PubMed  CAS  Google Scholar 

  134. Cox DJ, Gonder-Frederick LA, Julian DM, et al. Sex differences in plasma glucose thresholds for counterregulatory hormone release and hypoglycemia symptom perception. Diabetes Care 1996; 19: 269–70

    PubMed  CAS  Google Scholar 

  135. Amiel SA, Archibald HR, Chusney G, et al. Ketones diminish hormone responses to hypoglycemia-evidence for acute adaptation of cerebral metabolism to a non-glucose fuel [abstract]? Diabetologia 1989; 32: 460A

    Google Scholar 

  136. Fanelli C, Di Vincenzo A, Modarelli F, et al. Post-hypoglycemic hyperketonaemia does not contribute to brain metabolism during hypoglycaemia in humans. Diabetologia 1993; 36: 1191–7

    PubMed  CAS  Google Scholar 

  137. Veneman T, Mitrakou A, Mokan M, et al. Effect of hyper-ketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory responses during hypoglycemia in normal humans. Diabetes 1994; 43: 1311–7

    PubMed  CAS  Google Scholar 

  138. Maran A, Cranston I, Lomas J, et al. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994; 343: 16–20

    PubMed  CAS  Google Scholar 

  139. King P, Parkin H, Macdonald IA, et al. The effect of intravenous lactate on cerebral function during hypoglycemia. Diabetic Med 1997; 14: 19–28

    PubMed  CAS  Google Scholar 

  140. Bressler P, DeFronzo RA. Drug effects on glucose homeostasis. In: Alberti KGMM, Zimmet P, Defronzo RA, et al., editors. International textbook of diabetes mellitus. Chichester: John Wiley & Sons, 1997: 213–54

    Google Scholar 

  141. Pandit MK, Burke J, Gustafson AB, et al. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993; 118: 529–39

    PubMed  CAS  Google Scholar 

  142. Seltzer HS. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1989; 18: 163–83

    PubMed  CAS  Google Scholar 

  143. Kerr D. Drugs and alcohol. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 328–36

    Google Scholar 

  144. Kerr D, Reza M, Smith N, et al. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes 1991; 40: 1057–62

    PubMed  CAS  Google Scholar 

  145. Gengo FM, Gabos C, Straley C, et al. The pharmacodynamics of ethanol: effects on performance and judgement. J Clin Pharmacol 1990; 30: 748–54

    PubMed  CAS  Google Scholar 

  146. Peterson JB, Rothfleisch J, Zelazo PD. Acute alcohol intoxication and cognitive functioning. J Stud Alcohol 1990; 51: 114–22

    PubMed  CAS  Google Scholar 

  147. Peoples RW, Li C, Weight FF. Lipid vs protein theories of alcohol action in the nervous system. Annu Rev Pharmacol Toxicol 1996; 36: 185–201

    PubMed  CAS  Google Scholar 

  148. Kerr D, Macdonald IA, Heller SR, et al. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia 1990; 33: 216–21

    PubMed  CAS  Google Scholar 

  149. Kolaczynski JW, Ylikahri E, Härkonen M, et al. The acute effect of ethanol on counterregulatory response and recovery from insulin-induced hypoglycemia. J Clin Endocrinol Metab 1988; 67: 384–8

    PubMed  CAS  Google Scholar 

  150. Lecavalier L, Bolli G, Cryer P, et al. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol 1988; 256: E844–51

    Google Scholar 

  151. Molina PE, Jabbour K, Williams P, et al. Effect of acute ethanol intoxication on glucoregulation during prolonged insulininduced hypoglycemia. Am J Physiol 1994; 267: R1280–7

    PubMed  CAS  Google Scholar 

  152. Adler RA. Clinically important effects of alcohol on endocrine function. J Clini Endocrinol Metab 1992; 74: 957–60

    CAS  Google Scholar 

  153. Fanelli C, Calderone S, Epifano L, et al. Demonstration of a critical role of free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 1993; 92: 1617–22

    PubMed  CAS  Google Scholar 

  154. Avogaro A, Beltramello P, Gnudi L, et al. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypo- glycemia in IDDM patients: evidence for a critical role of free fatty acids. Diabetes 1993; 42: 1626–34

    PubMed  CAS  Google Scholar 

  155. Tattersall RB. Frequency and causes of hypoglycemia. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 176–89

    Google Scholar 

  156. Veneman T, Mitrakou A, Mokan M, et al. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993; 42: 1233–7

    PubMed  CAS  Google Scholar 

  157. Beaser RS, Hill JCV. The Joslin guide to diabetes. New York: A Fireside Book, Simon and Schuster, 1995

    Google Scholar 

  158. Kinsley BT, Weinger K, Bajaj M, et al. Blood glucose awareness training preserves epinephrine responses to hypoglycemia during intensive treatment in IDDM [abstract]. Diabetes 1997; 46 Suppl.: 42A

    Google Scholar 

  159. Cox DJ, Gonder-Frederick L, Julian D, et al. Intensive versus standard blood glucose awareness training (BGAT) with insulin-dependent diabetes: mechanisms and ancillary effects. Psychosom Med 1991; 53: 453–62

    PubMed  CAS  Google Scholar 

  160. Cox DJ, Gonder-Frederick L, Julian D, et al. Long-term follow-up evaluation of blood glucose awareness training. Diabetes Care 1994; 17: 1–5

    PubMed  CAS  Google Scholar 

  161. McCall AL. IDDM, counterregulation and the brain. Diabetes Care 1997; 20: 1228–30

    PubMed  CAS  Google Scholar 

  162. Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997; 20: 1231–6

    PubMed  CAS  Google Scholar 

  163. Kaufman FR, Halvorson M, Kaufman ND. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995; 30: 205–9

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katie Weinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weinger, K., Jacobson, A.M. Cognitive Impairment in Patients with Type 1 (Insulin-Dependent) Diabetes Mellitus. Mol Diag Ther 9, 233–252 (1998). https://doi.org/10.2165/00023210-199809030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199809030-00006

Keywords

Navigation